Biliary Tract Carcinoma — Trials

Biliary Tract Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

821 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 236
Recruiting: 137
Ph III recruiting: 9
Growth YoY: +9.1%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (111)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06963060	Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT)(GALENT-BT)	enrolling by invitation	Phase 2	44	Wei GongOTHER	1	May 8, 2025	clinicaltrials
NCT01868490	The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells	enrolling by invitation	Phase 1 / Phase 2	20	Siriraj HospitalOTHER	1	Feb 10, 2025	clinicaltrials